37 related articles for article (PubMed ID: 2656291)
1. Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.
Psaila B; Wang G; Rodriguez-Meira A; Li R; Heuston EF; Murphy L; Yee D; Hitchcock IS; Sousos N; O'Sullivan J; Anderson S; Senis YA; Weinberg OK; Calicchio ML; ; Iskander D; Royston D; Milojkovic D; Roberts I; Bodine DM; Thongjuea S; Mead AJ
Mol Cell; 2020 May; 78(3):477-492.e8. PubMed ID: 32386542
[TBL] [Abstract][Full Text] [Related]
2. Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders.
Mesa RA
Int J Hematol; 2002 Aug; 76 Suppl 2():193-203. PubMed ID: 12430925
[TBL] [Abstract][Full Text] [Related]
3. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.
Le Bousse-Kerdilès MC; Martyré MC
Springer Semin Immunopathol; 1999; 21(4):491-508. PubMed ID: 10945038
[No Abstract] [Full Text] [Related]
4. Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disorders.
Duensing S; Duensing A; Meran JG; Kreft A; Büsche G; Ganser A; Georgii A
Mol Pathol; 1999 Jun; 52(3):146-50. PubMed ID: 10621836
[TBL] [Abstract][Full Text] [Related]
5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
6. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
[TBL] [Abstract][Full Text] [Related]
8. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia.
Florensa L; Besses C; Woessner S; Solé F; Acín P; Pedro C; Sans-Sabrafen J
Leukemia; 1995 Feb; 9(2):271-3. PubMed ID: 7869763
[TBL] [Abstract][Full Text] [Related]
9. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.
Battegay EJ; Thomssen C; Nissen C; Gudat F; Speck B
Eur J Haematol; 1989 Apr; 42(4):321-6. PubMed ID: 2656291
[TBL] [Abstract][Full Text] [Related]
10. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
11. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
Yan L; Elkassar N; Gardin C; Briere J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]